You are here: Industry Insights > autoimmune

News List

New compound targets enzyme linked to autoimmune disorders, severe COVID-19 worldpharmanews
March 12, 2021
When the body detects a pathogen, such as bacteria or viruses, it mounts an immune system response to fight this invader. In some people, the immune system overreacts, resulting in an overactive immune response that causes the body to injure itself ...
FairJourney Biologics, IONTAS enter antibody discovery pact with Pandion Therapeutics expresspharma
November 24, 2020
Diverse panel of novel target binders from FairJourney Biologics and IONTAS will be used to uncover functional antibodies to advance autoimmune and inflammatory disease research.
Sanofi to acquire Principia Biopharma expresspharma
August 18, 2020
The deal adds to Sanofi’s R&D areas of autoimmune and allergic diseases.
Chinese Autoimmune Disease Drug Market: Which of the Competing Global Blockbuster Drugs Will Win? PharmaSources/1°C
December 05, 2019
Adalimumab has been “active” recently. Multiple adalimumab biosimilars are entering the harvest period in China following the arrival of China’s biosimilar era starting with ...
AstraZeneca’s SLE drug performs well in Phase III trial pharmaceutical-technology
September 03, 2019
AstraZeneca has announced anifrolumab met the primary endpoint of the Phase III Tulip trial studying 373 systemic lupus erythematosus (SLE) patients.
FTC investigates contracts regarding autoimmune disease drug, Remicade europeanpharmaceuticalreview
August 02, 2019
The US Federal Trade Commission is investigating whether Johnson and Johnson violated antitrust laws with its medication, Remicade.
Etanercept Tx for Autoimmune Disease May Up Risk for IBD drugs
July 16, 2019
Etanercept Tx for Autoimmune Disease May Up Risk for IBD.
When Traditional Rx Fails, Psoriasis Patients Seek Alternatives drugs
June 27, 2019
When traditional Rx fails, psoriasis patients seek alternatives.
Lilly and ImmuNext enter autoimmune disease research alliance pharmaceutical-technology
April 11, 2019
Lilly and ImmuNext enter autoimmune disease research alliance.
Abzena and Lipum AB Sign Integrated CMC Agreement to Produce a Novel Biologic for Autoimmune Inflammatory Diseases pharmafocusasia
March 20, 2019
Abzena, the global biologics gene to GMP partner research organization, announced it has signed an agreement to support an integrated CMC program with Lipum, a company developing treatments for chronic inflammatory diseases.

Previous page 1 2 Next page